Pharmacists in Valley Springs, CA Accepting Medicare
7 Pharmacists found. Showing 1 - 7
 Kathy Choi, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 E Highway 12 Ste D, Valley Springs, CA 95252 Phone: 209-772-9681 |
 Dr. John Nguyen, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1906 Vista Del Lago Dr., Suite G, Valley Springs, CA 95252 Phone: 209-920-3299 Fax: 209-920-3391 |
Brian Eugene Cobb, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1906 Vista Del Lago Dr, Suite G., Valley Springs, CA 95252 Phone: 209-980-3299 Fax: 209-920-3391 |
Kim Ngan T Pham, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 51 Wellness Way # 110, Valley Springs, CA 95252 Phone: 209-772-9088 |
Kyle Bertrand Rootsaert Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1906 Vista Del Lago Dr Ste G, Valley Springs, CA 95252 Phone: 209-920-3299 |
Mr. Gilbert C Leu, RPH Pharmacist - Ambulatory Care Medicare: Not Enrolled in Medicare Practice Location: 200 E Highway 12 Ste D, Valley Springs, CA 95252 Phone: 209-772-9681 |
Thuc Linh Tran, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 51 Wellness Way, Valley Springs, CA 95252 Phone: 209-584-9088 |
News Archive
FDA approves ipilimumab to treat metastatic melanoma
The US Food and Drug Administration announced today that the drug ipilimumab has been approved for the treatment of patients with metastatic melanoma. It is the first drug ever shown to improve overall survival for patients with advanced melanoma.
BRICS health ministers agree to improve access to low-cost medicines
Health ministers from Brazil, Russia, India, China, and South Africa in Beijing "on Monday vowed to improve access to low-cost and high-quality medicine - and called on developed nations to shoulder responsibility in helping the poor," Agence France-Presse reports.
Can-Fite seeks EMA Orphan Drug Designation for CF102 in HCC
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that are being developed to treat inflammatory diseases, cancer and sexual dysfunction, announced today it has submitted an application to the European Medicines Agency for Orphan Drug Designation for its drug candidate CF102 in the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.
New UCLA study sheds light on why some people develop PTSD
Why do some people develop post-traumatic stress disorder (PTSD) while others who suffered the same ordeal do not? A new UCLA discovery may shed light on the answer.
› Verified 7 days ago
Pharmacists
Dentists
Clinical Social Workers
Counselors
Marriage Counselors